中国医院统计
中國醫院統計
중국의원통계
CHINESE JOURNAL OF HOSPITAL STATISTICS
2015年
2期
111-113
,共3页
职工医保%住院费用%冠心病%影响因素
職工醫保%住院費用%冠心病%影響因素
직공의보%주원비용%관심병%영향인소
Urban medical insurance%Hospitalization expense%Coronary intervention%Influencing factor
目的:分析职工医保冠心病介入治疗患者住院费用及影响因素,为职工医保冠心病介入治疗患者住院费用控制提供依据。方法应用描述性统计分析、非参数检验、逐步多元线性回归分析等方法对徐州市某三级甲等医院2009年1月1日~2012年12月31日出院的职工医保冠心病介入治疗患者的住院费用进行分析,共计1851人次。结果职工医保冠心病介入治疗患者次均费用50966.01元,医用材料费、药费是职工医保冠心病介入治疗患者住院费用的主要构成,分别占63.9%及20.1%,多因素分析发现:住院天数是影响住院费用的首要因素。结论控制医疗费用的不合理增长应从控制医用材料费、药费和缩短无效住院日着手。
目的:分析職工醫保冠心病介入治療患者住院費用及影響因素,為職工醫保冠心病介入治療患者住院費用控製提供依據。方法應用描述性統計分析、非參數檢驗、逐步多元線性迴歸分析等方法對徐州市某三級甲等醫院2009年1月1日~2012年12月31日齣院的職工醫保冠心病介入治療患者的住院費用進行分析,共計1851人次。結果職工醫保冠心病介入治療患者次均費用50966.01元,醫用材料費、藥費是職工醫保冠心病介入治療患者住院費用的主要構成,分彆佔63.9%及20.1%,多因素分析髮現:住院天數是影響住院費用的首要因素。結論控製醫療費用的不閤理增長應從控製醫用材料費、藥費和縮短無效住院日著手。
목적:분석직공의보관심병개입치료환자주원비용급영향인소,위직공의보관심병개입치료환자주원비용공제제공의거。방법응용묘술성통계분석、비삼수검험、축보다원선성회귀분석등방법대서주시모삼급갑등의원2009년1월1일~2012년12월31일출원적직공의보관심병개입치료환자적주원비용진행분석,공계1851인차。결과직공의보관심병개입치료환자차균비용50966.01원,의용재료비、약비시직공의보관심병개입치료환자주원비용적주요구성,분별점63.9%급20.1%,다인소분석발현:주원천수시영향주원비용적수요인소。결론공제의료비용적불합리증장응종공제의용재료비、약비화축단무효주원일착수。
Objective To analyze the main influencing factors of the hospitalization expense of percutaneous coronary heart disease patients with medical insurance and to provide the theoretic evidences for the reasonable control of the medical ex-penses.Methods 1 851 urban medical insurance inpatients with percutaneous coronary heart disease were chosen and they were discharged from a first-rate hospital from January 1, 2012 to December 31, 2013 in Xuzhou city.The medical expenses were ana-lyzed with descriptive statistics, nonparametric test, stepwise multiple linear regression analysis methods.Results The average expenditure of percutaneous coronary heart disease patients with medical insurance was 50 966.01 Yuan.Medical consumables costs and drug costs made up the most expenses, accounting for 63.9% and 20.1% respectively.Hospitalization days was the primary affecting factor through multivariate analysis.Conclusion In order to control the growth of unreasonable medical costs, we should control medical consumables costs, drug costs and shorten the ineffective hospitalization days.